न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - atomoxetine hydrochloride 45.71mg equivalent to 40 mg atomoxetine free base - capsule - 40 mg - active: atomoxetine hydrochloride 45.71mg equivalent to 40 mg atomoxetine free base excipient: dimeticone gelatin indigo carmine pregelatinised maize starch sodium laurilsulfate tekprint black sw-9008 tekprint black sw-9010 titanium dioxide - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older and adolescents.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - atomoxetine hydrochloride 5.71mg equivalent to 5 mg atomoxetine free base - capsule - 5 mg - active: atomoxetine hydrochloride 5.71mg equivalent to 5 mg atomoxetine free base excipient: dimeticone gelatin iron oxide yellow pregelatinised maize starch sodium laurilsulfate tekprint black sw-9008 tekprint black sw-9010 - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older and adolescents.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - atomoxetine hydrochloride 68.56mg equivalent to 60 mg atomoxetine free base - capsule - 60 mg - active: atomoxetine hydrochloride 68.56mg equivalent to 60 mg atomoxetine free base excipient: dimeticone gelatin indigo carmine iron oxide yellow pregelatinised maize starch sodium laurilsulfate tekprint black sw-9008 tekprint black sw-9010 titanium dioxide - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older and adolescents.

न्यूज़ीलैंड - अंग्रेज़ी - Medsafe (Medicines Safety Authority)

eli lilly and company (nz) limited - atomoxetine hydrochloride 91.42mg equivalent to 80 mg atomoxetine free base - capsule - 80 mg - active: atomoxetine hydrochloride 91.42mg equivalent to 80 mg atomoxetine free base excipient: dimeticone gelatin   iron oxide red iron oxide yellow pregelatinised maize starch sodium laurilsulfate   tekprint black sw-9008   tekprint black sw-9010   titanium dioxide   - strattera is indicated for the treatment of attention-deficit/hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older and adolescents.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - atomoxetine hydrochloride, quantity: 5.71 mg (equivalent: atomoxetine, qty 5 mg) - capsule, hard - excipient ingredients: dimeticone 350; gelatin; sodium lauryl sulfate; pregelatinised maize starch; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - strattera is indicated for the treatment of attention deficit hyperactivity disorder (adhd) as defined by dsm-iv criteria in children 6 years of age and older, adolescents and adults.

ऑस्ट्रेलिया - अंग्रेज़ी - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - atomoxetine hydrochloride -

मलेशिया - अंग्रेज़ी - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - atomoxetine hydrochloride -

मलेशिया - अंग्रेज़ी - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - atomoxetine hydrochloride -

मलेशिया - अंग्रेज़ी - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - atomoxetine hydrochloride -

मलेशिया - अंग्रेज़ी - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - atomoxetine hydrochloride -